( S ( NP-SBJ-1 ( NP ( NNS Earnings ) ) ( PP ( IN for ) ( NP ( NP ( JJS most ) ) ( PP ( IN of ) ( NP ( NP ( DT the ) ( NN nation ) ( POS 's ) ) ( JJ major ) ( JJ pharmaceutical ) ( NNS makers ) ) ) ) ) ) ( VP ( VBP are ) ( VP ( VBN believed ) ( S ( VP ( TO to ) ( VP ( VB have ) ( VP ( VBN moved ) ( ADVP-DIR ( RB ahead ) ) ( ADVP-MNR ( RB briskly ) ) ( PP-TMP ( IN in ) ( NP ( DT the ) ( JJ third ) ( NN quarter ) ) ) ( SBAR-ADV ( IN as ) ( S ( NP-SBJ ( NP ( NNS companies ) ) ( PP ( IN with ) ( NP ( JJR newer ) ( JJ big-selling ) ( NN prescription ) ( NNS drugs ) ) ) ) ( VP ( VBD fared ) ( ADVP-MNR ( RB especially ) ( RB well ) ) ) ) ) ) ) ) ) ) ) )